Two Sigma Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
HF
IC
JF
XT
GS
Two Sigma Securities's LABD Position: Q2 2026 in Review
Two Sigma Securities opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 83,550 shares worth $644K. The stake represents 0.06% of the portfolio and ranks #472 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in LABD as recently as Q4 2025.
Two Sigma Securities first reported a position in LABD in Q4 2016 and has held it in 13 quarters since. The position peaked at $882K in Q2 2024. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.
- Two Sigma Securities held 83,550 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $644K as of Q2 2026.
- Direxion Daily S&P Biotech Bear 3X ETF was a new Two Sigma Securities position in Q2 2026.
- Direxion Daily S&P Biotech Bear 3X ETF made up 0.06% of Two Sigma Securities's portfolio in Q2 2026, its #472 holding.
- Two Sigma Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2016 and has held it in 13 quarters since.
- Two Sigma Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $882K in Q2 2024.
- 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.